IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses.
Tamburini BA, Kedl RM, Bellgrau D. IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses. J Immunother. 2012 Jan; 35(1):14-22.